Article
Updated International Consensus Guidelines for Advanced Breast Cancer Published
The guidelines have been published in 2 journals: Breast and Annals of Oncology.
The latest international consensus guidelines for the management of advanced were published online September 18 in the Annals of Oncology and September 20 in the Breast.
The advanced breast cancer 2 (ABC2) guidelines urge more research and clinical trials into treatment for advanced disease, and describe advanced breast cancer patients as a "historically neglected population."
In particular, the guidelines note, more research is needed to find the best treatments for patients with breast cancer that has spread to the liver, pleural cavity, or the skin; patients with HER2-positive advanced breast cancer who relapse during or shortly after adjuvant treatment with ; patients with stage IV disease; and men with advanced breast cancer who require treatment with aromatase inhibitors, such as , , and letrozole.
Link to the report on Medscape: http://bit.ly/1riuURB
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
